Rates of PSA screening in PLCO

Principal Investigator

Name
Jonathan Shoag

Degrees
MD

Institution
New York Presbyterian Hospital Weill Cornell

Position Title
Resident Physician

Email
jes9171@nyp.org

About this CDAS Project

Study
PLCO (Learn more about this study)

Project ID
PLCO-179

Initial CDAS Request Approval
Nov 20, 2015

Title
Rates of PSA screening in PLCO

Summary
The PLCO trial randomized men to usual care or annual PSA screening and DRE. We would like to examine the rates of screening in the intervention arms and the control arms during and after the study using the HSQ. This will provide insight into PSA screening in the community, and provide additional context to the debate on PSA screening.

Aims

1. Determine the rate of screening in the PLCO participants following the trial and in the control arm during the study.
2. Understand the demographics of PSA screening in the community.

Collaborators

NA

Related Publications

• Reevaluating PSA Testing Rates in the PLCO Trial.
  Shoag JE, Mittal S, Hu JC
  N. Engl. J. Med. 2016 May; Volume 374 (Issue 18): Pages 1795-6 PUBMED